Newsletters - September - October 2005

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

MethySelene®(Methylselenocys- teine) an ingredient manufactured by Sabinsa using a patented process (US Patent #6,794,537), has been nominated for the 2005 CPhI Innovation Award.

The annual Convention of Pharmaceutical Ingredients (CPhI) is the world's leading international exhibition for pharmaceutical ingredients, intermediates and allied industries. This year's event will be held on 1, 2, and 3 November 2005. This Expo event is a significant meeting place for the global pharmaceutical manufacturing industry.

The CPhI Innovation Awards recognize and celebrate advances in technology and science. The winners will be selected at the CPhI Worldwide 2005 event in Madrid, Spain. The entries will be judged by a panel of distinguished experts from the global pharmaceutical industry. In related news, a second patent application on novel compositions of methylselenocysteine for nutraceutical use, recently received a Notice of Allowance from the USPTO.

Randomized, double-blind, placebo-controlled; 30 overweight/obese male subjects; 12 weeks, Active therapy: 250 mg ForsLean®twice daily

Serum testosterone levels and bone mass also increased signific-cantly in the treated group.

    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos Certificate Logos Certificate Logos

CONTACT US